Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Revision as of 18:23, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For patient information click here

Template:DiseaseDisorder infobox

WikiDoc Resources for Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Articles

Most recent articles on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Most cited articles on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Review articles on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Articles on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Images of Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Photos of Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Podcasts & MP3s on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Videos on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Evidence Based Medicine

Cochrane Collaboration on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Bandolier on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

TRIP on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Clinical Trials

Ongoing Trials on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents at Clinical Trials.gov

Trial results on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Clinical Trials on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

NICE Guidance on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

NHS PRODIGY Guidance

FDA on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

CDC on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Books

Books on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

News

Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents in the news

Be alerted to news on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

News trends on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Commentary

Blogs on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Definitions

Definitions of Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Patient Resources / Community

Patient resources on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Discussion groups on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Patient Handouts on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Directions to Hospitals Treating Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Risk calculators and risk factors for Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Healthcare Provider Resources

Symptoms of Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Causes & Risk Factors for Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Diagnostic studies for Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Treatment of Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Continuing Medical Education (CME)

CME Programs on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

International

Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents en Espanol

Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents en Francais

Business

Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents in the Marketplace

Patents on Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Experimental / Informatics

List of terms related to Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents

Overview

Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, despite compliance with lifestyle recommendations.

Adjuvant therapies in children and adolescents

Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents [1] (DONOT EDIT)

The Role of Physical Activity in Management

1) From current pediatric data, it would appear that an exercise program should be included as part of a comprehensive risk factor modification program for the prevention of cardiovascular disease in children and adolescents.

2) Emphasis on regular physical activity rather than improvement in aerobic capacity appears to be the best approach for structuring such a program.

3) More long-term data are needed to completely assess the role of physical activity in risk factor modification for the pediatric population.

Nonpharmacological Therapies

1) In general, dietary recommendations should be consistent with good nutrition, aimed at a proper caloric balance to ensure optimal growth and development while preventing obesity.


References

  1. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP; et al. (2007). "Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing". Circulation. 115 (14): 1948–67. doi:10.1161/CIRCULATIONAHA.107.181946. PMID 17377073.

de:Hyperlipoproteinämie he:היפרליפידמיה sv:Hyperlipidemi


Template:WikiDoc Sources